Bharat Biotech to begin trials of intranasal vaccine for Covid in Feb-Mar
The Phase-1 trials will be conducted in Saint Louis University’s Vaccine and Treatment Evaluation Unit
- Explained: How Apple can tackle the $230 billion luxury car market
- TCS begins Q3 results season with a bang; net profit up 7.2% to Rs 8,701 cr